We are live on ! Find out more
PCMI

Paradigm Capital Management Inc Portfolio holdings

AUM $2.61B
1-Year Est. Return 78.58%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+78.58%
3 Year Est. Return
+164.7%
5 Year Est. Return
+201.05%
10 Year Est. Return
+1,210.21%
AUM
$1.1B
AUM Growth
-$41.9M
Cap. Flow
-$40.4M
Cap. Flow %
-3.68%
Top 10 Hldgs %
33.23%
Holding
171
New
9
Increased
41
Reduced
41
Closed
10

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$9.17M
2
TLYS icon
Tilly's
TLYS
+$5.85M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$5.26M
4
CALX icon
Calix
CALX
+$5.24M
5
RBBN icon
Ribbon Communications
RBBN
+$2.26M

Top Sells

Rank Stock Value
1
CRAY
Cray, Inc.
CRAY
+$20.2M
2
KTOS icon
Kratos Defense & Security Solutions
KTOS
+$16.2M
3
TTMI icon
TTM Technologies
TTMI
+$7.4M
4
UCTT
Ultra Clean Holdings
UCTT
+$6.45M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$5.72M

Sector Composition

Rank Sector Weight
1 Technology 41.23%
2 Industrials 19.31%
3 Healthcare 17.71%
4 Consumer Discretionary 13.35%
5 Consumer Staples 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
151
Accendra Health
ACH
$224M
$163K 0.01%
+51,000
New +$174K
P
152
Everpure Inc
P
$29B
$153K 0.01%
10,000
– –
COLL icon
153
Collegium Pharmaceutical
COLL
$944M
$131K 0.01%
+10,000
New +$134K
GNMK
154
DELISTED
GenMark Diagnostics, Inc
GNMK
$127K 0.01%
19,700
– –
FLXN
155
DELISTED
Flexion Therapeutics, Inc.
FLXN
$123K 0.01%
+10,000
New +$115K
CERS icon
156
Cerus
CERS
$468M
$112K 0.01%
20,000
– –
CRNT icon
157
Ceragon Networks
CRNT
$202M
$103K 0.01%
35,000
– –
OPTN
158
DELISTED
OptiNose
OPTN
$78K 0.01%
+733
New +$96.6K
CPRX
159
DELISTED
Catalyst Pharmaceutical
CPRX
$77K 0.01%
+20,000
New +$86.4K
SURF
160
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$28K ﹤0.01%
+10,000
New +$39.8K
AVNS
161
DELISTED
Avanos Medical
AVNS
– –
-6,160
Closed -$263K
ETD icon
162
Ethan Allen Interiors
ETD
$598M
– –
-61,200
Closed -$1.17M
PKOH icon
163
Park-Ohio Holdings
PKOH
$670M
– –
-7,150
Closed -$232K
SRTS icon
164
Sensus Healthcare
SRTS
$49.1M
– –
-41,000
Closed -$288K
TAK icon
165
Takeda Pharmaceutical
TAK
$54.4B
– –
-10,068
Closed -$205K
MODN
166
DELISTED
MODEL N, INC.
MODN
– –
-11,000
Closed -$193K
RESN
167
DELISTED
Resonant Inc.
RESN
– –
-51,000
Closed -$153K
FBM
168
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
– –
-80,000
Closed -$787K
AVP
169
DELISTED
Avon Products, Inc.
AVP
– –
-203,000
Closed -$597K
EMKR
170
DELISTED
Emcore Corp
EMKR
– –
-47,904
Closed -$1.75M
3 4 5 6
7

Similar funds

MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $2.6B AUM 83.27% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
GAG
GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Paradigm Capital Management Inc's Q2 2019 Portfolio in Review

As of Q2 2019, Paradigm Capital Management Inc held 171 positions worth $1.1B, down 3.7% from $1.14B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Paradigm Capital Management Inc withdrew a net $40.4M in Q2 2019, closing 10 positions and reducing 41 holdings. Its most notable exit was Emcore Corp, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Paradigm Capital Management Inc opened a new position in Axcelis worth $1.12M.

  • Paradigm Capital Management Inc's largest Q2 2019 buy was Axcelis: 74,300 shares worth $1.12M.
  • Paradigm Capital Management Inc added most to Globus Medical in Q2 2019, an estimated $9.17M increase.
  • Paradigm Capital Management Inc's biggest Q2 2019 reduction was Cray, Inc., cutting an estimated $20.2M.
  • Paradigm Capital Management Inc fully exited Emcore Corp in Q2 2019, selling an estimated $1.75M.
  • Paradigm Capital Management Inc's ten largest holdings make up 33% of its $1.1B portfolio in Q2 2019.
  • Paradigm Capital Management Inc opened 9 new positions and closed 10 in Q2 2019.
  • Paradigm Capital Management Inc's portfolio value fell 3.7% quarter-over-quarter to $1.1B.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2019, filed 8 Aug 2019.